InMode Ltd vs J M Smucker Co — how do they compare? InMode Ltd trades at $14.21 (market cap $809.93M), while J M Smucker Co trades at $119.83 (market cap $12.76B). The key difference: J M Smucker Co is far larger — about 15.8× InMode Ltd's market cap, and J M Smucker Co pays a 3.75% dividend while InMode Ltd pays none. Which is the better fit depends on your goals — on Pluang, investors hold InMode Ltd for 28 Days and J M Smucker Co for 74 Days on average.
| INMD | SJM | |
|---|---|---|
Market Cap | $809.93M | $12.76B |
Volume | 365,490 | 1,300,545 |
Sector | Health | Consumer Staples |
52-Week High | $16.62 | $132.34 |
52-Week Low | $12.76 | $89.53 |
Typical Hold Time | 28 Days | 74 Days |
Enterprise Value | $313.27M | $19.61B |
Dividend Yield | — | 3.75% |
Signals from Pluang's Aura AI — not financial advice
INMD trades at $14.08, up 0.5% with mixed technical signals showing bearish moving averages but neutral oscillators. The company maintains strong fundamentals with a P/E of 11.63, gross margins of 76.52%, and consistent revenue around $370M. Recent news includes product innovation with Morpheus8 Cool launch and an unsolicited acquisition offer from Steel Partners at $16.75 per share in July 2026.
Outlook remains cautious with analyst consensus divided (45% Buy, 55% Hold) amid cyclical softness. Investment opportunity lies in potential acquisition premium and international growth, while risks include US sales decline and management capital allocation concerns. The stock faces near-term resistance at $14 with support at the same level.
SJM trades at $119.41, up 3.0% today, with a bullish technical signal and positive earnings momentum after beating estimates for three consecutive quarters. The stock shows strong analyst support with a consensus price target of $138.23, though high valuation ratios and recent net losses highlight fundamental challenges. Recent news highlights robust growth in segments like Uncrustables and raised fiscal 2027 guidance, but investor caution persists due to margin pressures and competitive headwinds in the consumer staples sector.
The outlook for SJM is cautiously optimistic, driven by earnings beats and strategic brand strength, but risks include volatile profitability, elevated debt, and sector competition. Upside potential exists if the company sustains revenue growth and improves net margins, aligning with analyst targets, though macroeconomic factors and execution risks could limit near-term gains.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
InMode provides innovative medical technologies for minimally invasive surgical procedures. Its platforms use radiofrequency (RF) energy for aesthetic treatments like body contouring and skin tightening.
Read more on INMD →J.M. Smucker is a packaged food company that primarily operates in the U.S. retail channel (87% of fiscal 2022 revenue), but also in U.S. food-service (7%), and international (6%). Its largest segment is pet food and treats (36% of 2022 revenue), with popular brands such as Milk-Bone, Meow Mix, 9Lives, Kibbles 'n Bits, Nature's Recipe, and Rachael Ray Nutrish. Its second-largest category is coffee (35% across channels) with the number-two brand Folgers and number-six Dunkin'. Other large categories are peanut butter (10%), with number-one Jif, fruit spreads (5%) with number-one Smucker's, and frozen hand-held foods (6%) with number-one Uncrustables.
Read more on SJM →